| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 09/14/2004 | US6790637 Mammalian gene, BCL-W, belongs to the BCL-2 family of apoptosis-controlling genes |
| 09/14/2004 | US6790606 Extracellular matrix signaling molecules |
| 09/14/2004 | CA2088258C Nuclease resistant, pyrimidine modified oligonucleotides that detect and modulate gene expression |
| 09/10/2004 | WO2004077060A2 Assay for detection of renal cell carcinoma |
| 09/10/2004 | WO2004076674A1 Delivery of sirna to cells using polyampholytes |
| 09/10/2004 | WO2004076668A1 Modified tert promoter with enhanced tumor-specificity and strength and recombinant vector comprising the same |
| 09/10/2004 | WO2004076667A1 Double-strand rna oligonucleotide having effect of inhibiting the expression of cyclin b gene |
| 09/10/2004 | WO2004076648A2 Clinically relevant animal model of human breast cancer and vegf involement in desmoplastic response. |
| 09/10/2004 | WO2004076645A2 Compositions and methods for cytomegalovirus treatment |
| 09/10/2004 | WO2004076644A2 A composition for delivering an agent to a target cell and uses thereof |
| 09/10/2004 | WO2004076639A2 Use of gene expression profiling in the diagnosis and treatment of lupus nephritis and systemic lupus erythematosus |
| 09/10/2004 | WO2004076635A2 Therapeutic applications of thrombomodulin gene via viral and non-viral vectors |
| 09/10/2004 | WO2004076633A2 Hypoxia inducible vegf plasmid for ischemic disease |
| 09/10/2004 | WO2004076627A2 Method of using adenoviral vectors with increased persistence in vivo |
| 09/10/2004 | WO2004076626A2 Methods of gene therapy for treating disorders of the ear by administering a vector encoding an atonal-associated factor |
| 09/10/2004 | WO2004076623A2 Rna-interference for znfn3a1-gene as a method for inhibiting cancer cell growth |
| 09/10/2004 | WO2004076482A1 Soluble factor secreted by endothelial cells in blood vessels |
| 09/10/2004 | WO2004075971A1 Microseeding device for gene delivery by microneedle injection |
| 09/10/2004 | WO2004075911A1 Chemokine binding protein and use thereof |
| 09/10/2004 | WO2004075835A2 Methods for the treatment of renal cell carcinoma |
| 09/10/2004 | WO2004075723A2 Methods for the early diagnosis of ovarian cancer |
| 09/10/2004 | WO2004058175A3 Novel use of liver x receptor agonists |
| 09/10/2004 | WO2004044131A8 Cross-linked oligomeric compounds and their use in gene modulation |
| 09/10/2004 | WO2004043222A3 Treating carcinoid neoplasms with therapeuthic viruses |
| 09/10/2004 | WO2004029287A3 Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis or treatment of liver disorders and epithelial cancer |
| 09/10/2004 | WO2004016731A3 Ex-vivo expansion of hematopoietic stem cell populations in mononuclear cell cultures |
| 09/10/2004 | WO2004009759A3 Novel proteins in enteroaggregative escherichia coli (eaec) useful for diagnosis and therapy of eaec infections |
| 09/10/2004 | WO2003092594A3 Adeno-associated viral vectors and methods for their production from hybrid adenovirus and for their use |
| 09/10/2004 | WO2003091397A3 Methods and compositions for regulating cellular signaling |
| 09/10/2004 | WO2003070897A3 RNA INTERFERENCE MEDIATED INHIBITION OF TNF AND TNF RECEPTOR SUPERFAMILY GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 09/10/2004 | WO2002098890A3 MARKs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 09/10/2004 | WO2002092840A3 Agents that regulate apoptosis |
| 09/10/2004 | CA2519193A1 Methods for the early diagnosis of ovarian cancer |
| 09/10/2004 | CA2517294A1 Method of using adenoviral vectors with increased persistencein vivo |
| 09/10/2004 | CA2517082A1 Clinically relevant animal model of human breast cancer and vegf involvement in desmoplastic response |
| 09/10/2004 | CA2516727A1 Hypoxia inducible vegf plasmid for ischemic disease |
| 09/10/2004 | CA2516588A1 Assay for detection of renal cell carcinoma |
| 09/10/2004 | CA2515916A1 Therapeutic applications of thrombomodulin gene via viral and non-viral vectors |
| 09/10/2004 | CA2514781A1 Methods of gene therapy for treating disorders of the ear by administering a vector encoding an atonal-associated factor |
| 09/10/2004 | CA2514329A1 Methods for the treatment of renal cell carcinoma |
| 09/09/2004 | US20040177388 Methods and compositions for the identification and treatment of neurodegenerative disorders |
| 09/09/2004 | US20040176582 Expression vector comprising osteocalcin promoter and nucleotide sequence coding bone morphogenic protein for treatment and prevention of osteoporosis |
| 09/09/2004 | US20040176576 Antibodies against cancer |
| 09/09/2004 | US20040176473 Methods for delivering compounds into a cell |
| 09/09/2004 | US20040176318 Pretreating with lipophilic substituted saccharide |
| 09/09/2004 | US20040176298 Methods for identifying compounds for regulating muscle mass or function using vasoactive intestinal peptide receptors |
| 09/09/2004 | US20040176292 Methods and compositions for enhancing cognitive function using morphogenic proteins |
| 09/09/2004 | US20040176286 Use of agt and its derivatives for manufacturing anti-angiogenesis pharmaceutical compositions |
| 09/09/2004 | US20040176285 Tip39 polypeptides |
| 09/09/2004 | US20040176282 Cellular delivery and activation of polypeptide-nucleic acid complexes |
| 09/09/2004 | US20040176275 Pharmaceutical composition for alleviating tissue hypoxia and methods for alleviating tissue hypoxia |
| 09/09/2004 | US20040175815 kit for treating chronic obstructive pulmonary disease, cancer, and diseases in which cell signaling is defective |
| 09/09/2004 | US20040175813 can be delivered separately or in combination with apoptotic inducing agents via aerosol liposome/transfection/infection methods to treat cellular proliferative diseases and disorders in humans and animals |
| 09/09/2004 | US20040175803 Interferon-alpha induced gene |
| 09/09/2004 | US20040175794 for angiogenic diseases (cancer, cancer metasis, chronic inflammatory disorders, rheumatoid arthritis, atherosclerosis, macular degeneration, diabetic retinopathy), restenosis, Alzheimer's disease and tissue remodeling; genetic engineering |
| 09/09/2004 | US20040175772 for drug screening cancer drugs and tumor activators/suppressors; fluorescence resonance energy transfer; genetic engineering |
| 09/09/2004 | US20040175730 Comprises nucleotide sequences coding polypeptide associated with vascular permeability or proliferation of endothelial cells for treating intestinal malabsorption syndrome |
| 09/09/2004 | US20040175714 Human protooncogene kg-20 and protein encoded therein |
| 09/09/2004 | US20040175703 to be administered by inhalation, infusion, injection, or orally relates to double-stranded ribonucleic acid (dsRNA), and its use in mediating RNA interference in vitro and in vivo; genetic engineering |
| 09/09/2004 | US20040175700 Using phenotypic, genotypic, physiological and morphogenic variation profiles to diagnose and prognose genetic disorders; genomics |
| 09/09/2004 | US20040175699 Nucleotide sequences coding myosin binding protein-C 3-cardiac (MYBPC) regulatory sequence for use as gene therapeutic tools in expressing proteins for treating cardiomyopathies, myocardial infarction and cardiac rhythm disorders |
| 09/09/2004 | US20040175698 Regulation of human latrophilin-like g protein-coupled receptor |
| 09/09/2004 | US20040175393 Cloning and recombinant production of polistinae venom enzymes, such as phospholipase and hyaluronidase, and imunological therapies based thereon |
| 09/09/2004 | US20040175375 Downregulation of c-myc by promoting the ubiquitination of FBP, by administering an isolated p38/JTV-1protein or fragment or an isolated nucleic acid encoding said protein; |
| 09/09/2004 | US20040175371 Introducing a biological material into a patient |
| 09/09/2004 | US20040175370 Injecting aqueous solution containing an expression vector comprising desired gene; gene therapy wherein hepatocyte growth factor (HGF) gene is introduced by electroporation into kidney to be transplanted |
| 09/09/2004 | US20040175369 Stat3 antagonists and their use as vaccines against cancer |
| 09/09/2004 | US20040175364 Gene transfer with adenoviruses having modified fiber proteins |
| 09/09/2004 | US20040175363 Defective recombinant adenovirus; treatment of neurodenerative, cardiovascular, brain, genetic, nervous system and respiratory system disorders; Alzheimer's, Parkinson's, amyotrophic lateral sclerosis (ALS), atherosclerosis, and/or trisomy 2; adult respiratory distress syndrome; anticarcinogenic agents |
| 09/09/2004 | US20040175362 Infectivity-enhanced conditionally-replicative adenovirus and uses thereof |
| 09/09/2004 | US20040173778 homogeneous clonal populations derived therefrom with enhanced suppressive activity and their uses in the regulation of immune responses and for the identification and characterization of suppressor T cell specific molecules |
| 09/08/2004 | EP1455190A1 Modulation of the activity of nuclear receptors via EWS |
| 09/08/2004 | EP1454989A1 Infectious HCV pseudo-particles containing native functional E1 and E2 envelope proteins |
| 09/08/2004 | EP1454988A1 Infectious flavivirus pseudo-particles containing functional prM-E envelope proteins |
| 09/08/2004 | EP1454984A1 Pharmaceutical compositions and their use, namely for the treatment of neurodegenerative diseases |
| 09/08/2004 | EP1454917A2 Diabody-type bispecific antibody |
| 09/08/2004 | EP1454628A2 Medical use of p38/JTV-1 |
| 09/08/2004 | EP1454142A2 Inhibition of tristetraproline for protection of the heart from cardiac injuries |
| 09/08/2004 | EP1454136A2 Methods and means for influencing intracellular communication and intracellular organelle transport |
| 09/08/2004 | EP1453977A2 Molecular characteristics of non-small cell lung cancer |
| 09/08/2004 | EP1453962A2 Inhibitor oligonucleotides and their use for specific repression of a gene |
| 09/08/2004 | EP1453954A2 Endocrine pancreas differentiation of adipose tissue-derived stromal cells and uses thereof |
| 09/08/2004 | EP1453953A1 Method for producing stem cells with increased developmental potential |
| 09/08/2004 | EP1453856A1 Beta-amyloid binding factors and inhibitors thereof |
| 09/08/2004 | EP1453855A1 Antimicrobial bolisin peptides |
| 09/08/2004 | EP1453854A2 Human cdnas and proteins and uses thereof |
| 09/08/2004 | EP1453853A2 Mixture of peptides originating from a nef protein and applications thereof |
| 09/08/2004 | EP1453849A2 Antisense modulation of purinoreceptor p2x3 |
| 09/08/2004 | EP1453845A2 Compositions of nucleic acids and cationic aminoglycosides and methods of using and preparing the same |
| 09/08/2004 | EP1453568A1 Techniques for treating neurodegenerative disorders by brain infusion of mutational vectors |
| 09/08/2004 | EP1453548A2 Compositions for and methods of treating and preventing sirs/sepsis |
| 09/08/2004 | EP1453547A2 Adeno-associated virus (aav) serotype 8 sequences, vectors containing same, and uses therefor |
| 09/08/2004 | EP1453543A2 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 09/08/2004 | EP1453537A1 Composition for viral preservation |
| 09/08/2004 | EP1453536A1 Composition for the preservation of viruses |
| 09/08/2004 | EP1453533A1 Migration of hematopoietic stem cells and progenitor cells to th e liver |
| 09/08/2004 | EP1453531A2 Use of hmgb proteins and nucleic acids that code therefor |
| 09/08/2004 | EP1453382A2 Methods and compositions for correction of cardiac conduction disturbances |
| 09/08/2004 | EP1409510A4 Biological pacemaker |
| 09/08/2004 | EP1174501B1 Gene expression base sequences for therapeutic use and drugs for gene therapy |